‌

US Patent 8877197 Anti-complement C1s

Patent 8877197 was granted and assigned to True North Therapeutics on November, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

True North Therapeutics

Current Assignee

True North Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8877197

Date of Patent

November 4, 2014

Patent Application Number

14152565

Date Filed

January 10, 2014

Patent Citations Received

‌

US Patent 11958899 Anti-C1s antibodies and uses thereof

Patent Primary Examiner

‌

Phillip Gambel

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8877197 Anti-complement C1s

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API